Kerentech

Kerentech is rated 3 out of 5 in the category venture capital & private equity. Read and write reviews about Kerentech. Specialties: Search of Investors for Life Sciences and Medtech Companies Facilitating Outlicense, Joint Ventures, M&A Specific business development related with pharma, biotech and medtech IP trade and negotiation We are based both in Spain and Israel and our clients are around the world, including: United States, United Kingdom, France, Israel, Spain, India, China, Hong-Kong. Minimal Transaction Requirements : Drug Development-2M euro, protected IP, Proof of concept in animals. Medtech:-2 M euro, Working Beta prototype, protected IP. Our experience ranges from start-ups and spin-offs to PIPE in Nasdaq quoted Companies, phase III transactions. We also do fundraising for incubators, funds and operations between funds specialized in Life Sciences. Team experience: more than 40 accumulated years; Company funded in 2003 Contact: info (at) kerentech.com